四环素抗生素:潜在的抗癌药物
Jiayu Li1, Yuan Qin2, Chenhao Zhao1
1College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
European journal of pharmacology
|August 4, 2023
概括
美国食品和药物管理局批准的四环素抗生素,如多西环素,显示出抗癌性质,抑制癌症的进展和转移. 这些药物可以与化疗结合使用,以改善患者的生存率和生活质量.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 最初以抗菌性质而闻名的四环素抗生素越来越多地研究抗癌效应.
- 多西环素,米诺环素和tigecycline是FDA批准的四环素,具有已证明的抗癌潜力.
研究的目的:
- 审查多克西环素,米诺环素和tigecycline的抗癌机制.
- 探索它们在各种癌症的联合疗法中的有效性.
- 总结它们作为临床癌症治疗中的辅助药物的作用.
主要方法:
- 关于四环素抗生素和癌症的研究文献综述.
- 作用机制的分析,包括抗扩散,抗转移,自和亡.
- 检查与化疗和向药物的联合治疗数据.
主要成果:
- 多西环素,米诺环素和tigecycline通过多个途径表现出抗癌活性.
- 这些四环素在组合疗法中显示出有前途,以抑制癌症的进展.
- 它们可以缓解副作用,并改善接受化疗的患者的生存率.
结论:
- 多西环素,米诺环素和提格环素是具有双重抗菌和抗癌功能的有前途的药物类别.
- 对它们的机制和临床应用进行进一步的研究可以增强癌症治疗策略.
- 确定研究缺口和未来方向对于优化它们的治疗用途至关重要.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


